Valerie L. Durkalski-Mauldin

Title
InstitutionMedical University of South Carolina
DepartmentPublic Health Sciences
AddressP.O. Box MSC 835
305J
Cannon Place - 135 Cannon St.
Phone843-876-1911
Fax843-876-1923
vCardDownload vCard

    Collapse Overview 
    Collapse keywords
    Design, conduct and analysis of clinical trials, Neurological emergencies and digestive diseases, Design and analysis of non-inferiority studies

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. MacDonald AJ, Subramanian RM, Olson JC, Speiser JL, Durkalski-Mauldin VL, Abraldes JG, Bigam DL, Flynn MM, Rapaka B, Shropshire BM, Vora RS, Karvellas CJ. Use of the Molecular Adsorbent Recirculating System in Acute Liver Failure: Results of a Multicenter Propensity Score-Matched Study. Crit Care Med. 2022 02 01; 50(2):286-295. PMID: 34259656.
      Citations:    
    2. Korley FK, Durkalski-Mauldin V, Callaway CW. Convalescent Plasma for Outpatients with Covid-19. Reply. N Engl J Med. 2021 12 02; 385(23):2206-2207. PMID: 34644469.
      Citations:    
    3. Korley FK, Durkalski-Mauldin V, Yeatts SD, Schulman K, Davenport RD, Dumont LJ, El Kassar N, Foster LD, Hah JM, Jaiswal S, Kaplan A, Lowell E, McDyer JF, Quinn J, Triulzi DJ, Van Huysen C, Stevenson VLW, Yadav K, Jones CW, Kea B, Burnett A, Reynolds JC, Greineder CF, Haas NL, Beiser DG, Silbergleit R, Barsan W, Callaway CW. Early Convalescent Plasma for High-Risk Outpatients with Covid-19. N Engl J Med. 2021 11 18; 385(21):1951-1960. PMID: 34407339.
      Citations:    
    4. Stravitz RT, Fontana RJ, Meinzer C, Durkalski-Mauldin V, Hanje AJ, Olson J, Koch D, Hamid B, Schilsky ML, McGuire B, Ganger D, Liou I, Karvellas CJ, Rule JA, Lisman T, Clasen K, Reuben A, Cripps M, Lee WM. Coagulopathy, Bleeding Events, and Outcome According to Rotational Thromboelastometry in Patients With Acute Liver Injury/Failure. Hepatology. 2021 08; 74(2):937-949. PMID: 33636020.
      Citations:    
    5. Schreiner AD, Livingston S, Zhang J, Gebregziabher M, Marsden J, Koch DG, Petz CA, Durkalski-Mauldin VL, Mauldin PD, Moran WP. Identifying Patients at Risk for Fibrosis in a Primary Care NAFLD Cohort. J Clin Gastroenterol. 2021 Jul 22. PMID: 34294656.
      Citations:    
    6. Schreiner AD, Zhang J, Durkalski-Mauldin V, Livingston S, Marsden J, Bian J, Mauldin PD, Moran WP, Rockey DC. Advanced liver fibrosis and the metabolic syndrome in a primary care setting. Diabetes Metab Res Rev. 2021 11; 37(8):e3452. PMID: 33759300.
      Citations:    
    7. Fukuda-Doi M, Yamamoto H, Koga M, Palesch YY, Durkalski-Mauldin VL, Qureshi AI, Yoshimura S, Okazaki S, Miwa K, Okada Y, Ueda T, Okuda S, Nakahara J, Suzuki N, Toyoda K. Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2. Stroke. 2020 08; 51(8):2282-2286. PMID: 32623977.
      Citations:    
    8. Bruno A, Johnston KC, Durkalski-Mauldin VL. Treatment of Hyperglycemia in Patients With Acute Stroke-Reply. JAMA. 2019 12 10; 322(22):2248-2249. PMID: 31821427.
      Citations:    
    9. Cotton P, Pauls Q, Wood A, Durkalski-Mauldin V. Maintaining the blind in sham controlled interventional trials: lessons from the EPISOD study. Endosc Int Open. 2019 Nov; 7(11):E1322-E1326. PMID: 31673601.
      Citations:    
    10. Coté GA, Durkalski-Mauldin VL, Serrano J, Klintworth E, Williams AW, Cruz-Monserrate Z, Arain M, Buxbaum JL, Conwell DL, Fogel EL, Freeman ML, Gardner TB, van Geenen E, Groce JR, Jonnalagadda SS, Keswani RN, Menon S, Moffatt DC, Papachristou GI, Ross A, Tarnasky PR, Wang AY, Wilcox CM, Hamilton F, Yadav D. SpHincterotomy for Acute Recurrent Pancreatitis Randomized Trial: Rationale, Methodology, and Potential Implications. Pancreas. 2019 09; 48(8):1061-1067. PMID: 31404020.
      Citations:    
    11. Schreiner AD, Bian J, Zhang J, Haulsee ZM, Marsden J, Durkalski-Mauldin V, Mauldin PD, Moran WP, Rockey DC. The Association of Abnormal Liver Tests with Hepatitis C Testing in Primary Care. Am J Med. 2020 02; 133(2):214-221.e1. PMID: 31369723.
      Citations:    
    12. Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, Fansler A, Van de Bruinhorst K, Janis S, Durkalski-Mauldin VL. Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial. JAMA. 2019 07 23; 322(4):326-335. PMID: 31334795.
      Citations:    
    13. Jiang Y, Zhao W, Durkalski-Mauldin V. Time-trend impact on treatment estimation in two-arm clinical trials with a binary outcome and Bayesian response adaptive randomization. J Biopharm Stat. 2020; 30(1):69-88. PMID: 31017843.
      Citations:    
    14. Spivak I, Arora J, Meinzer C, Durkalski-Mauldin V, Lee WM, Trautwein C, Fontana RJ, Strnad P. Low Serum Hepcidin Is Associated With Reduced Short-Term Survival in Adults With Acute Liver Failure. Hepatology. 2019 05; 69(5):2136-2149. PMID: 30582749.
      Citations:    
    15. Johnston KC, Durkalski-Mauldin VL. Considering prehospital stroke trials: did RIGHT-2 get it right? Lancet. 2019 03 09; 393(10175):963-965. PMID: 30738650.
      Citations:    
    16. Schreiner AD, Mauldin PD, Moran WP, Durkalski-Mauldin V, Zhang J, Schumann SO, Heincelman ME, Marsden J, Rockey DC. Assessing the Burden of Abnormal LFTs and the Role of the Electronic Health Record: A Retrospective Study. Am J Med Sci. 2018 Jun; 355(6):537-543. PMID: 29673744.
      Citations:    
    17. Jiang Y, Zhao W, Durkalski-Mauldin V. Impact of adaptation algorithm, timing, and stopping boundaries on the performance of Bayesian response adaptive randomization in confirmative trials with a binary endpoint. Contemp Clin Trials. 2017 11; 62:114-120. PMID: 28866294.
      Citations:    
    18. Cotton PB, Pauls Q, Keith J, Thornhill A, Drossman D, Williams A, Durkalski-Mauldin V. The EPISOD study: long-term outcomes. Gastrointest Endosc. 2018 Jan; 87(1):205-210. PMID: 28455162.
      Citations:    
    19. Suarez AL, Pauls Q, Durkalski-Mauldin V, Cotton PB. Sphincter of Oddi Manometry: Reproducibility of Measurements and Effect of Sphincterotomy in the EPISOD Study. J Neurogastroenterol Motil. 2016 Jul 30; 22(3):477-82. PMID: 26951046.
      Citations:    
    20. Pauls Q, Durkalski-Mauldin V, Brawman-Mintzer O, Lawrence C, Whichard R, Cotton PB. Duloxetine for the Treatment of Patients with Suspected Sphincter of Oddi Dysfunction: A Pilot Study. Dig Dis Sci. 2016 09; 61(9):2704-9. PMID: 27165434.
      Citations:    
    21. Welch RD, Nicholas K, Durkalski-Mauldin VL, Lowenstein DH, Conwit R, Mahajan PV, Lewandowski C, Silbergleit R. Intramuscular midazolam versus intravenous lorazepam for the prehospital treatment of status epilepticus in the pediatric population. Epilepsia. 2015 Feb; 56(2):254-62. PMID: 25597369.
      Citations:    
    22. Durkalski V. Adaptive designs: a true panacea for the common clinical trial? Ann Emerg Med. 2012 Oct; 60(4):449-50. PMID: 22699015.
      Citations:    
    23. Durkalski V, Silbergleit R, Lowenstein D. Challenges in the design and analysis of non-inferiority trials: a case study. Clin Trials. 2011 Oct; 8(5):601-8. PMID: 21921062.
      Citations:    
    24. Durkalski V, Stewart W, MacDougall P, Mauldin P, Romagnuolo J, Brawman-Minzter O, Cotton P. Measuring episodic abdominal pain and disability in suspected sphincter of Oddi dysfunction. World J Gastroenterol. 2010 Sep 21; 16(35):4416-21. PMID: 20845508.
      Citations:    
    25. Durkalski V, Dillon C, Kim J. A web-based clinical trial management system for a sham-controlled multicenter clinical trial in depression. Clin Trials. 2010 Apr; 7(2):174-82. PMID: 20083496.
      Citations:    
    26. Durkalski VL, Berger VW. Re-formulating non-inferiority trials as superiority trials: The case of binary outcomes. Biom J. 2009 Feb; 51(1):185-92. PMID: 19197960.
      Citations:    
    27. Durkalski VL, Palesch YY, Lipsitz SR, Rust PF. Analysis of clustered matched-pair data. Stat Med. 2003 Aug 15; 22(15):2417-28. PMID: 12872299.
      Citations:    
    28. Durkalski VL, Palesch YY, Lipsitz SR, Rust PF. Analysis of clustered matched-pair data for a non-inferiority study design. Stat Med. 2003 Jan 30; 22(2):279-90. PMID: 12520562.
      Citations:    
    Durkalski-Mauldin's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (141)
    Explore
    _
    Co-Authors (18)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _